PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?
NPJ Breast Cancer. 2019;5:1
Authors: Pondé N, Gelber RD, Piccart M
PMID: 30675511 [PubMed]
from A via a.sfakia on Inoreader http://bit.ly/2Dy6Acb
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?
NPJ Breast Cancer. 2019;5:1
Authors: Pondé N, Gelber RD, Piccart M
PMID: 30675511 [PubMed]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,